Open AccessCase of possible encephalopathy following receiving the first dose of Iranian COVID‐19Vaccine; COVIran Barakat
Author(s) -
Fallahi Mohammad Javad,
Esmaeilzadeh Shahri Navid,
Khodamoradi Zohre,
Meymandi Nia Moazameh,
Sehatpour Faezeh,
Mahmoudi Laleh
Publication year - 2022
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.5661
Subject(s) - medicine , encephalopathy , medical diagnosis , covid-19 , pediatrics , altered mental status , differential diagnosis , toxic encephalopathy , radiology , psychiatry , pathology , disease , infectious disease (medical specialty)
We report a case of possible encephalopathy after receiving the first dose of Iran's COVIran Barekat vaccine. The patient had no history of neurological or mental illness. Clinical examinations and radiology reports were performed and differential diagnoses were analyzed by the treatment team. Finally, the possible association between vaccination and encephalopathy was concluded.